secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001104659-25-029612
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio launches larger OviTex PRS sizes for plastic/reconstructive surgery
----------------------------------------------------------------------------

- Larger sizes include 25x30 cm oval and 25 cm diameter circle, the largest option on the market.
- OviTex PRS is the only reinforced polymer-suture tissue matrix for plastic/reconstructive surgery.
- Nearly 15,000 units sold since 2019; 31% YoY unit growth in 2024.
- New configurations aim to reduce need for multiple smaller pieces and simplify complex procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925029612/0001104659-25-029612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925029612/tm2510876d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-029612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer